24
total announcements
BAJAJHCARE.NS · 15 min delayed
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing on stock exchanges.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has received a recommendation from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) for the grant of permission to manufacture and market Cenobamate Tablets.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to the sale of its operational business unit and the declaration of un-audited financial results.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has approved the sale of an operational business unit located in Tarapur for up to ₹4.05 Crores, with completion expected by October 31, 2026. This unit contributed a minor 0.54% to the company's revenue and 0.74% to its net worth in the last financial year, indicating a negligible financial impact. The buyer, M/s Orchem Products, is an unrelated party, and the transaction is not considered a related party transaction.